跳至主要内容
临床试验/CTRI/2020/01/022671
CTRI/2020/01/022671尚未招募不适用

A comparative study between recipient site preparation using manual dermabrasion and electrofulguration assisted dermabrasion in autologous non cultured epidermal cell suspension procedure in stable vitiligo patients and correlation of growth factors in the cell suspension with clinical response

Department of Dermatology Venereology and Leprology PGIMER1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年1月13日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To assess the percentage of patients achieving 75 percent repigmentation with respect to the two different methods at 24 weeks of follow up post treatment

研究概览

简要总结

Vitiligo is a common acquired disorder of pigmentation and causes considerable cosmetic disfigurement and psychological distress to patients. Surgical therapy is a good treatment option for stable patches not responding to conventional methods of therapy. The gold standard of recipient site preparation in NCES procedure is manual dermabrasion. However our centre has reported good outcome with recipient site preparation using electrofulguration assisted dermabrasion. In this study we propose to compare the repigmentation rates using the two methods of recipient site preparation. In addition, the keratinocytes in the cell suspension are a rich source of various growth factors which stimulate the melanocytes to produce melanin and cause repigmentation. Hence we wish to correlate the levels of growth factors like SCF, bFGF, Endothelin 1 in the cell suspension with the repigmentation rates post surgery.

研究设计

研究类型
Interventional
分配方式
Random Number Table
盲法
Not Applicable

入排标准

年龄范围
0.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Clinical diagnosis of segmental or non segmental vitiligo 2 independent patchesbof 3x 3 cm size each present symmetrically or unilaterally over the same part or a single patch ofvsize 6x6 cm Stable leaions for more than 1 year Disease is not responding to medical therapy for 12 weeks or residual patches post medical therapy.

排除标准

  • Pregnancy and lactation History of unstable cardiac diseasevor pacemakers Patients with active disease VIDA more than 1 History of hypertrophic scars or keloid Skin infection Patients with unrealistic expectations History of bleeding disorders Patients on anticoagulants Immunosuppressed patients Patients still in wash off period of therapy that is 4 weeks for topical and 12 weeks for systemic therapy.

结局指标

主要结局

To assess the percentage of patients achieving 75 percent repigmentation with respect to the two different methods at 24 weeks of follow up post treatment

时间窗: 0 4 8 12 16 24 weeks

次要结局

  • To assess whether the extent of repigmentation has any correlation to the expression levels of growth factors which are SCF, bFGF, endothelin 1(0 4 8 12 16 24 weeks)
  • To evaluate the repigmentation patterns of the lesions pre and post post procedure by dermoscopy and to ennumerate the dermatoscopic markers of repigmentation as well markers of success of the procedure(0 4 8 12 16 24 weeks)

研究者

发起方
Department of Dermatology Venereology and Leprology PGIMER
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验